The extent of metabolism of inhaled anesthetics in humans
- PMID: 3740510
- DOI: 10.1097/00000542-198608000-00013
The extent of metabolism of inhaled anesthetics in humans
Abstract
To determine the percentage of anesthetic metabolized and to assess the role of metabolism in the total elimination of inhaled anesthetics, the authors administered isoflurane, enflurane, halothane, and methoxyflurane simultaneously, for 2 h, to nine healthy patients. Total anesthetic uptake during the 2 h of washin and total recovery of unchanged anesthetic in exhaled gases during 5 to 9 days of washout were measured, and from these the per cent of anesthetic uptake that was recovered was calculated. Of the isoflurane taken up, 93 +/- 4% (mean +/- SE) was recovered. To compensate for factors other than metabolism that limit complete recovery of unchanged anesthetic, the percentage recovery of each anesthetic was normalized to the percentage recovery of isoflurane (which it was assumed undergoes no metabolism). Deficits in normalized recovery were assumed to be due to metabolism of the anesthetics. The resulting estimates of metabolism of anesthetic taken up were: enflurane 8.5 +/- 1.0%, halothane 46.1 +/- 0.9%, and methoxyflurane 75.3 +/- 1.6%. These results indicate that elimination is primarily via the lungs for isoflurane and enflurane, equally via the lungs and via metabolism for halothane, and primarily via metabolism for methoxyflurane.
Similar articles
-
Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans?Anesth Analg. 1987 Jan;66(1):1-8. Anesth Analg. 1987. PMID: 3800013
-
Pharmacokinetics of inhaled anesthetics in humans: measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide.Anesth Analg. 1986 Jun;65(6):575-82. Anesth Analg. 1986. PMID: 3706798
-
Effect of streptozotocin-induced diabetes in the rat on the metabolism of fluorinated volatile anesthetics.Anesthesiology. 1987 Jan;66(1):24-8. doi: 10.1097/00000542-198701000-00005. Anesthesiology. 1987. PMID: 3541691
-
Clinical pharmacokinetics of the inhalational anaesthetics.Clin Pharmacokinet. 1987 Mar;12(3):145-67. doi: 10.2165/00003088-198712030-00001. Clin Pharmacokinet. 1987. PMID: 3555939 Review.
-
Uptake and clearance of inhalation anesthetics in man.Drug Metab Rev. 1979;9(1):43-60. doi: 10.3109/03602537909046433. Drug Metab Rev. 1979. PMID: 376257 Review.
Cited by
-
Comparative tolerability profiles of the inhaled anaesthetics.Drug Saf. 1997 Mar;16(3):157-70. doi: 10.2165/00002018-199716030-00002. Drug Saf. 1997. PMID: 9098654 Review.
-
Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications.Paediatr Drugs. 2006;8(3):139-50. doi: 10.2165/00148581-200608030-00001. Paediatr Drugs. 2006. PMID: 16774294 Review.
-
Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.Drugs. 1996 Apr;51(4):658-700. doi: 10.2165/00003495-199651040-00009. Drugs. 1996. PMID: 8706599 Review.
-
Isoflurane preconditioning provides neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial activation.Sci Rep. 2015 Jun 18;5:11445. doi: 10.1038/srep11445. Sci Rep. 2015. PMID: 26086415 Free PMC article.
-
PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.BMC Anesthesiol. 2002 Aug 15;2(1):5. doi: 10.1186/1471-2253-2-5. BMC Anesthesiol. 2002. PMID: 12182764 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources